Detalles de la búsqueda
1.
Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting-results from the German Hepatitis C-Registry (DHC-R).
J Viral Hepat
; 28(8): 1206-1218, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34003549
2.
Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C-Registry.
Liver Int
; 41(7): 1518-1522, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33966349
3.
Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real-world data from the German Hepatitis C-Registry.
Liver Int
; 41(5): 949-955, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33592123
4.
Multiscale dynamic modeling and simulation of a biorefinery.
Biotechnol Bioeng
; 116(10): 2561-2574, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31237684
5.
GPU-Accelerated Adjoint Algorithmic Differentiation.
Comput Phys Commun
; 200: 300-311, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26941443
6.
Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C.
J Infect Dis
; 203(5): 595-601, 2011 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21257738
7.
Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R).
Viruses
; 14(7)2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35891520
8.
Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R).
Eur J Gastroenterol Hepatol
; 34(1): 76-83, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32956186
9.
Real-World Clinical Management of Patients with Primary Biliary Cholangitis-A Retrospective Multicenter Study from Germany.
J Clin Med
; 10(5)2021 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33806503
10.
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C-Registry.
Aliment Pharmacol Ther
; 49(8): 1052-1059, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30874328
11.
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
PLoS One
; 10(12): e0145622, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26699619
12.
Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial.
PLoS One
; 10(6): e0128069, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26057627
13.
Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography.
Theranostics
; 4(10): 960-71, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25157277
14.
Treatment of naïve patients with chronic hepatitis C genotypes 2 and 3 with pegylated interferon alpha and ribavirin in a real world setting: relevance for the new era of DAA.
PLoS One
; 9(10): e108751, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25302676
15.
The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV(+) patients with acute and chronic hepatitis C virus co-infection.
AIDS
; 24(13): 2001-7, 2010 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20588168
Resultados
1 -
15
de 15
1
Próxima >
>>